BaxDUO ARCTIC (Recruiting)
a Phase III, Randomised, Double-Blind, Active-Controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in
Participants with CKD and High Blood Pressure
- Medicine
- Baxdrostat
- Population
- Primairy prevention cardiovasular disease
- Phase
- III
- Starting year
- 2023